Headlines

Teladoc’s Outlook Clouds As JPMorgan Points To Uncertainty In Behavioral Health, Margin Pressure

JP Morgan analyst Lisa C. Gill maintained Neutral rating on TDOC with $9 price target, down from $11. Teladoc reports Q1 revenue of $629.4M.

Latest Ratings for TDOC

Date Firm Action From To
Mar 2022 Piper Sandler Maintains Overweight
Mar 2022 UBS Maintains Neutral
Mar 2022 Argus Research Upgrades Hold Buy

View More Analyst Ratings for TDOC

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *